Search research articles
Contact Us
Filters
Showing results (161-170 of 173) with videos related to
Page
of 18
Sort By:
Frontiers in Immunology
|
June 26, 2023
Eicosapentaenoic acid-rich oil supplementation activates PPAR-γ and delays skin wound healing in type 1 diabetic mice
Beatriz Burger, Roberta Nicolli Sagiorato, Jéssica Rondoni Silva, et al.
Leukemia
|
July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
G Martinelli, M Mancini, C De Benedittis, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
American Journal of Hematology
|
April 11, 2016
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
Lisa Pieri, Patrizia Bonadonna, Chiara Elena, et al.
Blood Cancer Journal
|
October 7, 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Fabio Guolo, Luana Fianchi, Paola Minetto, et al.
American Journal of Hematology
|
January 20, 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Giovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, et al.
Orphanet Journal of Rare Diseases
|
August 8, 2020
Consensus based recommendations for diagnosis and medical management of Poland syndrome (sequence)
Ilaria Baldelli, Alessio Baccarani, Chiara Barone, et al.
Blood Advances
|
March 6, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.
Cancers
|
July 14, 2023
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience
Luana Fianchi, Fabio Guolo, Francesco Marchesi, et al.
Hematological Oncology
|
August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
Monica Bocchia, Anna Candoni, Erika Borlenghi, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 173) with videos related to
Sort By:
Page
of 18
Frontiers in Immunology
|
June 26, 2023
Eicosapentaenoic acid-rich oil supplementation activates PPAR-γ and delays skin wound healing in type 1 diabetic mice
Beatriz Burger, Roberta Nicolli Sagiorato, Jéssica Rondoni Silva, et al.
Leukemia
|
July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
G Martinelli, M Mancini, C De Benedittis, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
American Journal of Hematology
|
April 11, 2016
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
Lisa Pieri, Patrizia Bonadonna, Chiara Elena, et al.
Blood Cancer Journal
|
October 7, 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program
Fabio Guolo, Luana Fianchi, Paola Minetto, et al.
American Journal of Hematology
|
January 20, 2025
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Giovanni Marconi, Elisabetta Petracci, Giuseppe Lanzarone, et al.
Orphanet Journal of Rare Diseases
|
August 8, 2020
Consensus based recommendations for diagnosis and medical management of Poland syndrome (sequence)
Ilaria Baldelli, Alessio Baccarani, Chiara Barone, et al.
Blood Advances
|
March 6, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML
Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.
Cancers
|
July 14, 2023
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience
Luana Fianchi, Fabio Guolo, Francesco Marchesi, et al.
Hematological Oncology
|
August 7, 2019
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
Monica Bocchia, Anna Candoni, Erika Borlenghi, et al.
Page
of 18